Gould Robert J
Director at FULC; Director at Epizyme, Inc.
- Sold, on record
- $18.1M
- Dollars the filings state
- Form 4 sales
- 34
- Latest Feb 2, 2026
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- FULCFulcrum Therapeutics, Inc.Director
- Epizyme, Inc.Director
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- Epizyme, Inc.542,108 shares
- FULC340,420 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale FULCUnusualApr 5, 2022 2022
Sold 94,251 shares at $24.16 ($2.3M)
Gould Robert J, Director
Sold 15.7% of holdings ($14.5M position)506,630 shares left33.6x usual sizeFiling
- 2 Form 4 sale FULCPlan not statedApr 7, 2022 +2 days
Sold 5,631 shares at $24.02 ($135k)
Gould Robert J, Director
Sold 1.1% of holdings ($12.3M position)506,630 shares left1.8x usual sizeFiling
- 3 Form 4 sale FULCUnusualJun 6, 2022 +60 days
Sold 66,622 shares at $8.00 ($533k)
Gould Robert J, Director
Sold 11.6% of holdings ($4.6M position)506,630 shares left14.7x usual sizeFiling
- 4 Form 4 sale FULCUnusualJun 7, 2022 +1 day
Sold 71,435 shares at $8.09 ($578k)
Gould Robert J, Director
Sold 12.4% of holdings ($4.7M position)506,630 shares left8.7x usual sizeFiling
- 5 Form 4 sale FULCPlan not statedJan 13, 2023 +220 days
Sold 6,766 shares at $15.00 ($101k)
Gould Robert J, Interim President & CEO
Sold 1.3% of holdings ($7.6M position)499,864 shares left0.7x usual sizeFiling
- 6 Form 4 sale FULCNo planNov 19, 2025 +1041 days
Sold 15,000 shares at $11.03 ($165k)
Gould Robert J, Director
No 10b5-1 planSold 3% of holdings ($5.5M position)484,864 shares leftFirst sale on recordFiling
- 7 Form 4 sale FULCNo planJan 2, 2026 +44 days
Sold 15,000 shares at $11.87 ($178k)
Gould Robert J, Director
No 10b5-1 planSold 3.1% of holdings ($5.8M position)469,864 shares leftFiling
- 8 Form 4 sale FULCNo planFeb 2, 2026 +31 days
Sold 15,000 shares at $10.72 ($161k)
Gould Robert J, Director
No 10b5-1 planSold 3.2% of holdings ($5M position)454,864 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (34)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Feb 2, 2026 | Feb 4, 2026 | FULC | Director | Form 4 sale | 15,000 | $161k | 3.2% | No plan | SEC |
| Jan 2, 2026 | Jan 6, 2026 | FULC | Director | Form 4 sale | 15,000 | $178k | 3.1% | No plan | SEC |
| Nov 19, 2025 | Nov 21, 2025 | FULC | Director | Form 4 sale | 15,000 | $165k | 3.0% | No plan | SEC |
| Jan 13, 2023 | Jan 13, 2023 | FULC | Interim President & CEO | Form 4 sale | 6,766 | $101k | 1.3% | Plan not stated | SEC |
| Jun 7, 2022 | Jun 8, 2022 | FULC | Director | Form 4 sale | 71,435 | $578k | 12.4% | Unusual | SEC |
| Jun 6, 2022 | Jun 6, 2022 | FULC | Director | Form 4 sale | 66,622 | $533k | 11.6% | Unusual | SEC |
| Apr 7, 2022 | Apr 11, 2022 | FULC | Director | Form 4 sale | 5,631 | $135k | 1.1% | Plan not stated | SEC |
| Apr 5, 2022 | Apr 5, 2022 | FULC | Director | Form 4 sale | 94,251 | $2.3M | 15.7% | Unusual | SEC |
| Mar 16, 2021 | Mar 17, 2021 | FULC | Officer, Director | Form 4 sale | 10,000 | $122k | 1.9% | Unusual | SEC |
| Feb 16, 2021 | Feb 18, 2021 | FULC | Officer, Director | Form 4 sale | 8,215 | $117k | 1.6% | Unusual | SEC |
| Jan 20, 2021 | Jan 22, 2021 | FULC | Officer, Director | Form 4 sale | 10,000 | $121k | 1.9% | Unusual | SEC |
| Jul 8, 2020 | Jul 9, 2020 | FULC | Officer, Director | Form 4 sale | 2,500 | $50k | 0.5% | Plan not stated | SEC |
| Jun 25, 2020 | Jun 26, 2020 | FULC | Officer, Director | Form 4 sale | 2,500 | $52k | 0.5% | Plan not stated | SEC |
| Jun 9, 2020 | Jun 10, 2020 | FULC | Officer, Director | Form 4 sale | 156 | $3k | 0.0% | Plan not stated | SEC |
| Jun 5, 2020 | Jun 9, 2020 | FULC | Officer, Director | Form 4 sale | 3,433 | $69k | 0.6% | Plan not stated | SEC |
| Jun 4, 2020 | Jun 5, 2020 | FULC | Officer, Director | Form 4 sale | 2,800 | $56k | 0.5% | Plan not stated | SEC |
| Jun 2, 2020 | Jun 3, 2020 | FULC | Officer, Director | Form 4 sale | 2,802 | $56k | 0.5% | Plan not stated | SEC |
| May 29, 2020 | Jun 1, 2020 | FULC | Officer, Director | Form 4 sale | 3,309 | $66k | 0.6% | Plan not stated | SEC |
| May 26, 2020 | May 28, 2020 | FULC | Officer, Director | Form 4 sale | 2,500 | $50k | 0.5% | Plan not stated | SEC |
| Feb 19, 2020 | Feb 20, 2020 | FULC | Officer, Director | Form 4 sale | 2,500 | $50k | 0.4% | Plan not stated | SEC |
| Dec 30, 2015 | Dec 31, 2015 | Epizyme, Inc. | Director | Form 4 sale | 32,108 | $578k | 100.0% | Unusual | SEC |
| Sep 8, 2015 | Sep 10, 2015 | Epizyme, Inc. | President & CEO | Form 4 sale | 60,000 | $1.2M | 100.0% | Unusual | SEC |
| Aug 3, 2015 | Aug 5, 2015 | Epizyme, Inc. | President & CEO | Form 4 sale | 60,000 | $1.3M | 100.0% | Unusual | SEC |
| Jul 6, 2015 | Jul 8, 2015 | Epizyme, Inc. | President & CEO | Form 4 sale | 60,000 | $1.4M | 100.0% | Unusual | SEC |
| Nov 3, 2014 | Nov 4, 2014 | Epizyme, Inc. | President & CEO | Form 4 sale | 30,000 | $749k | 100.0% | Unusual | SEC |
| Oct 1, 2014 | Oct 3, 2014 | Epizyme, Inc. | President & CEO | Form 4 sale | 30,000 | $788k | 100.0% | Unusual | SEC |
| Sep 2, 2014 | Sep 4, 2014 | Epizyme, Inc. | CEO | Form 4 sale | 30,000 | $1M | 100.0% | Unusual | SEC |
| Aug 1, 2014 | Aug 5, 2014 | Epizyme, Inc. | CEO | Form 4 sale | 30,000 | $907k | 100.0% | Unusual | SEC |
| Jul 1, 2014 | Jul 3, 2014 | Epizyme, Inc. | CEO | Form 4 sale | 30,000 | $946k | 100.0% | Unusual | SEC |
| Jun 2, 2014 | Jun 4, 2014 | Epizyme, Inc. | CEO | Form 4 sale | 30,000 | $666k | 100.0% | Unusual | SEC |
| May 1, 2014 | May 5, 2014 | Epizyme, Inc. | CEO | Form 4 sale | 30,000 | $657k | 100.0% | Unusual | SEC |
| Apr 7, 2014 | Apr 8, 2014 | Epizyme, Inc. | CEO | Form 4 sale | 30,000 | $607k | 100.0% | Unusual | SEC |
| Feb 10, 2014 | Feb 12, 2014 | Epizyme, Inc. | CEO | Form 4 sale | 60,000 | $1.8M | 100.0% | Unusual | SEC |
| Jan 2, 2014 | Jan 6, 2014 | Epizyme, Inc. | President and CEO | Form 4 sale | 30,000 | $605k | 100.0% | Unusual | SEC |